Walvax Biotechnology Hits Day High with Strong 5.12% Intraday Surge

Walvax Biotechnology Co., Ltd. has shown significant activity today, with the stock rising by 5.12% as of July 10, 2026. The stock reached an intraday high of CNY 13.38, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index declined by 1.0% on the same day. Over the past month, Walvax has demonstrated a notable increase of 14.06%, significantly outperforming the Shanghai Composite, which saw a modest gain of just 0.07%. Year-to-date, the stock has risen by 20.44%, while the composite index has only managed a 0.69% increase. Despite some challenges in long-term growth metrics, such as a decline in net sales and operating profit over the past five years, the company has reported positive results recently. Key performance indicators include a return on capital employed (ROCE) of 3.39% and a pre-tax profit of CNY 148.23 million. With a market capitalization of CNY 17,496 million, Walvax continues to maintain a competitive position within the pharmaceuticals and biotechnology industry.